Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Divalproex Sodium NDC 55648-973 by Wockhardt Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bottle label - Divalproex DR Tablets Container Labels 125 mg 100 Tab

bottle label - Divalproex DR Tablets Container Labels 125 mg 100 Tab

This is a product description for Divalproex Sodium, which is a medication in tablet form used to treat seizures, migraines, and bipolar disorder. The tablets are delayed-release and contain 125 mg of Valproic acid activity. It is important to dispense the medication with a patient information sheet and store it in a light-resistant container. The medication is manufactured by Wockhardt Limited in Mumbai, India and distributed by Wockhardt USA LLC in Parsippany, NJ.*

bottle label - Divalproex DR Tablets Container Labels 250 mg 500 Tab

bottle label - Divalproex DR Tablets Container Labels 250 mg 500 Tab

This is a description of a medication called Divalproex Sodium, which comes in the form of delayed-release tablets. These tablets contain Valproic Acid Activity and are dispensed with a patient information sheet. This medication is used to treat various medical conditions, although it is not specified which ones. Each tablet contains Divalproex sodium equivalent to 250 mg of Valproic acid, and it is recommended to store the medication in a USP tight, light-resistant container stored at 20°-25°C (68*77°F) (See USP Controlled Room Temperature). The manufacturer of this medicine is Wockharat, and it is distributed by a company located in Parsippany, NJ 07054. This description does not include any non-English characters, therefore, no exclusion is required.*

bottle label - Divalproex DR Tablets Container Labels 500 mg 500 Tab

bottle label - Divalproex DR Tablets Container Labels 500 mg 500 Tab

This is a description of a medication called Divalproex Sodium Delayed-Release Tablets USP. Each tablet contains 500 mg of Valproic Acid Activity. This medication is dispensed in a USP tight, light-resistant container and should be stored between 20°-25°C (68°-77°F). It is manufactured by Wockhardt Limited in Mumbai, India, and distributed by Wockhardt USA LLC in Parsippany, NJ.*

figure1 - figure1

figure1 - figure1

figure2 - figure2

figure2 - figure2

This is a description of two studies involving Placebo Divalproex Sodium delayed-release tablets. No further information is available.*

figure3 - figure3

figure3 - figure3

This text presents a graph showing the % reduction in CPS rate for patients taking Divalproex Sodium Delayed-Release Tablets. It shows that 50% of the patients experienced an improvement in their condition, while some others had no change or even worsening.*

figure4 - figure4

figure4 - figure4

strecture - structure01

strecture - structure01

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.